IMOVAX RABIES

Product Overview

About IMOVAX RABIES

IMOVAX RABIES is a vaccine designed to provide protection against rabies, a deadly viral disease that affects the nervous system. It contains an inactivated rabies virus, which is unable to cause the disease but still stimulates the body's immune response to produce antibodies.

Key Benefits & Uses

• Prevention of rabies in individuals who have been bitten or exposed to the virus.
• Post-exposure prophylaxis (PEP) to prevent the development of rabies in individuals who have been bitten or exposed to the virus.
• Pre-exposure prophylaxis (PrEP) to provide long-term protection against rabies for individuals at high risk of exposure, such as laboratory workers and veterinarians.

Active Ingredient & Action

IMOVAX RABIES contains INACTIVATED RABIES VIRUS (PM/WI38 1503-3M) as its active ingredient. When administered, this inactivated virus stimulates the body's immune system to produce antibodies against the rabies virus. These antibodies provide long-term protection against the disease, helping to prevent the virus from replicating and causing harm to the nervous system.

Important Notes

IMOVAX RABIES should only be administered by a healthcare professional. It is essential to follow the recommended dosing schedule and to complete the full course of vaccination to ensure optimal protection against rabies. Individuals with a history of severe allergic reactions or other medical conditions should consult their healthcare provider before receiving the vaccine.